| pubmed-article:15161048 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15161048 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
| pubmed-article:15161048 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:15161048 | lifeskim:mentions | umls-concept:C2266856 | lld:lifeskim |
| pubmed-article:15161048 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
| pubmed-article:15161048 | lifeskim:mentions | umls-concept:C0059438 | lld:lifeskim |
| pubmed-article:15161048 | pubmed:issue | 2B | lld:pubmed |
| pubmed-article:15161048 | pubmed:dateCreated | 2004-5-26 | lld:pubmed |
| pubmed-article:15161048 | pubmed:abstractText | Cancer-related molecular targets of green tea polyphenols, such as (-)-epigallocatechin-3-gallate [(-)-EGCG], remain unknown. We previously showed that (-)-EGCG is a potent and specific inhibitor of the proteasomal chymotrypsin-like activity in vitro and in vivo. | lld:pubmed |
| pubmed-article:15161048 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15161048 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15161048 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15161048 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:15161048 | pubmed:author | pubmed-author:WangZhigangZ | lld:pubmed |
| pubmed-article:15161048 | pubmed:author | pubmed-author:KaziAslamuzza... | lld:pubmed |
| pubmed-article:15161048 | pubmed:author | pubmed-author:DouQ PingQP | lld:pubmed |
| pubmed-article:15161048 | pubmed:author | pubmed-author:ChanTak-HangT... | lld:pubmed |
| pubmed-article:15161048 | pubmed:author | pubmed-author:KumarNaveenN | lld:pubmed |
| pubmed-article:15161048 | pubmed:author | pubmed-author:FalsettiSamue... | lld:pubmed |
| pubmed-article:15161048 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15161048 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:15161048 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15161048 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15161048 | pubmed:pagination | 943-54 | lld:pubmed |
| pubmed-article:15161048 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:meshHeading | pubmed-meshheading:15161048... | lld:pubmed |
| pubmed-article:15161048 | pubmed:articleTitle | Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors. | lld:pubmed |
| pubmed-article:15161048 | pubmed:affiliation | Drug Discovery Program, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, Florida 33612, USA. | lld:pubmed |
| pubmed-article:15161048 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15161048 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15161048 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:15161048 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15161048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15161048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15161048 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15161048 | lld:pubmed |
